Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 2Phase 2 1

Status

Completed 19Recruiting 6Terminated 4No longer available 1Active not recruiting 1

Sponsor Class

INDUSTRY 6OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other solid neoplasm 6

Conditions

Carcinoma, Non-Small-Cell Lung 429Breast Neoplasms 298Neoplasms 296Colorectal Neoplasms 242Neoplasm Metastasis 197Ovarian Neoplasms 171Lung Neoplasms 150Recurrence 147Prostatic Neoplasms 146Pancreatic Neoplasms 142Multiple Myeloma 136Stomach Neoplasms 129Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Leukemia, Myeloid, Acute 115Endometrial Neoplasms 115Advanced Solid Tumors 113Advanced Solid Tumor 108Carcinoma, Hepatocellular 102Triple Negative Breast Neoplasms 101Small Cell Lung Carcinoma 88Uterine Cervical Neoplasms 86Lymphoma, Non-Hodgkin 83Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Hematologic Neoplasms 62

Interventions

Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Solid Tumours × Clear all
NCT06815575 2026-06-02

A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.

Racura Oncology Ltd

Phase 1 Recruiting
53 enrolled
Other solid neoplasm

Solid Tumours

NCT07446855 2026-05-26

PARTHENON

AstraZeneca

Phase 1/2 Recruiting
180 enrolled
Other solid neoplasm

Solid Tumours

NCT07160725 2026-05-15

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

Phase 1/2 Recruiting
315 enrolled
Other solid neoplasm

Solid Tumours

NCT06725758 2026-05-08

TEADES

Orion Corporation, Orion Pharma

Phase 1/2 Recruiting
315 enrolled
Other solid neoplasm

Solid Tumours

NCT06581432 2026-04-29

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Boehringer Ingelheim

Phase 2 Recruiting
430 enrolled
Other solid neoplasm

Solid Tumours

NCT07165067 2025-12-29

A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors

AP Biosciences Inc.

Phase 1 Recruiting
36 enrolled
Other solid neoplasm

Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡